{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:05:35Z","timestamp":1775106335199,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s13555-026-01697-y","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T04:18:09Z","timestamp":1773202689000},"page":"1919-1931","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk of Cancer in Patients with Hidradenitis Suppurativa: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2780-3604","authenticated-orcid":false,"given":"Daniel","family":"Isufi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikkel Bak","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolai","family":"Loft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rune Kj\u00e6rsgaard","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"issue":"2","key":"1697_CR1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMCP1014163","volume":"366","author":"GBE Jemec","year":"2012","unstructured":"Jemec GBE. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012;366(2):158\u201364. https:\/\/doi.org\/10.1056\/NEJMCP1014163.","journal-title":"N Engl J Med"},{"key":"1697_CR2","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1001\/JAMADERMATOL.2020.1281","volume":"156","author":"R Kj\u00e6rsgaard Andersen","year":"2020","unstructured":"Kj\u00e6rsgaard Andersen R, Jorgensen IF, Reguant R, Jemec GBE, Brunak S. Disease trajectories for hidradenitis suppurativa in the Danish population. JAMA Dermatol. 2020;156:780\u20136. https:\/\/doi.org\/10.1001\/JAMADERMATOL.2020.1281.","journal-title":"JAMA Dermatol"},{"issue":"5","key":"1697_CR3","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1111\/BJD.14024","volume":"173","author":"T Tzellos","year":"2015","unstructured":"Tzellos T, Zouboulis CC, Gulliver W, Cohen AD, Wolkenstein P, Jemec GBE. Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2015;173(5):1142\u201355. https:\/\/doi.org\/10.1111\/BJD.14024.","journal-title":"Br J Dermatol"},{"issue":"2","key":"1697_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/JDV.12567","volume":"29","author":"E Shavit","year":"2015","unstructured":"Shavit E, Dreiher J, Freud T, Halevy S, Vinker S, Cohen AD. Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2015;29(2):371\u20136. https:\/\/doi.org\/10.1111\/JDV.12567.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1697_CR5","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1007\/S12325-019-00964-Z","volume":"36","author":"D Aletaha","year":"2019","unstructured":"Aletaha D, Epstein AJ, Skup M, Zueger P, Garg V, Panaccione R. Risk of developing additional immune-mediated manifestations: a retrospective matched cohort study. Adv Ther. 2019;36:1672\u201383. https:\/\/doi.org\/10.1007\/S12325-019-00964-Z.","journal-title":"Adv Ther"},{"issue":"1","key":"1697_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/J.DET.2015.07.003","volume":"34","author":"IE Deckers","year":"2016","unstructured":"Deckers IE, Kimball AB. The handicap of hidradenitis suppurativa. Dermatol Clin. 2016;34(1):17\u201322. https:\/\/doi.org\/10.1016\/J.DET.2015.07.003.","journal-title":"Dermatol Clin"},{"key":"1697_CR7","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1001\/pubs.ArchDermatol.-ISSN-0003-987x-137-6-dst00132","volume":"137","author":"J Lapins","year":"2001","unstructured":"Lapins J, Ye W, Nyr\u00e9n O, Emtestam L. Incidence of cancer among patients with hidradenitis suppurativa. Arch Dermatol. 2001;137:730\u20134. https:\/\/doi.org\/10.1001\/pubs.ArchDermatol.-ISSN-0003-987x-137-6-dst00132.","journal-title":"Arch Dermatol"},{"issue":"8","key":"1697_CR8","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/JAMADERMATOL.2020.1422","volume":"156","author":"JM Jung","year":"2020","unstructured":"Jung JM, Lee KH, Kim YJ, Chang SE, Lee MW, Choi JH, et\u00a0al. Assessment of overall and specific cancer risks in patients with hidradenitis suppurativa. JAMA Dermatol. 2020;156(8):844\u201353. https:\/\/doi.org\/10.1001\/JAMADERMATOL.2020.1422.","journal-title":"JAMA Dermatol"},{"key":"1697_CR9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.2340\/1651-226X.2024.26182","volume":"63","author":"RK Andersen","year":"2024","unstructured":"Andersen RK, Rostgaard K, Pedersen O, Jemec GBE, Hjalgrim H. Increased cancer incidence among patients with hidradenitis suppurativa\u2014a Danish nationwide register study 1977\u20132017. Acta Oncol. 2024;63:220\u20138. https:\/\/doi.org\/10.2340\/1651-226X.2024.26182.","journal-title":"Acta Oncol"},{"issue":"4","key":"1697_CR10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/JAMADERMATOL.2020.0024","volume":"156","author":"S Vaengebjerg","year":"2020","unstructured":"Vaengebjerg S, Skov L, Egeberg A, Loft ND. Prevalence, incidence, and risk of cancer in patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis. JAMA Dermatol. 2020;156(4):421\u20139. https:\/\/doi.org\/10.1001\/JAMADERMATOL.2020.0024.","journal-title":"JAMA Dermatol"},{"key":"1697_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100768","author":"M Beydon","year":"2023","unstructured":"Beydon M, Pinto S, De Rycke Y, Fautrel B, Mariette X, Seror R, et\u00a0al. Risk of cancer for patients with rheumatoid arthritis versus general population: a national claims database cohort study. Lancet Region Health Eur. 2023. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100768.","journal-title":"Lancet Region Health Eur"},{"key":"1697_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/S13643-016-0384-4","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev. 2016. https:\/\/doi.org\/10.1186\/S13643-016-0384-4.","journal-title":"Syst Rev"},{"key":"1697_CR13","doi-asserted-by":"crossref","unstructured":"Roster K, Fleshner L, Farabi B, Safai B. Social determinants of health and comorbidities in hidradenitis suppurativa using an inclusive database. 2024 [cited 2025 May 8]. https:\/\/www.pagny.org\/uploads\/images\/headshots\/Social-Determinants-of-Health-and-Comorbidities-in-Hidradenitis-Suppurativa-Using-an-Inclusive-Database.pdf. Accessed 8 May 2025","DOI":"10.1016\/j.jid.2024.06.1173"},{"key":"1697_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/S40257-024-00844-5","volume":"25","author":"HT Brydges","year":"2024","unstructured":"Brydges HT, Onuh OC, Friedman R, Barrett J, Betensky RA, Lu CP, et\u00a0al. Autoimmune, autoinflammatory disease and cutaneous malignancy associations with hidradenitis suppurativa: a cross-sectional study. Am J Clin Dermatol. 2024;25:473\u201384. https:\/\/doi.org\/10.1007\/S40257-024-00844-5.","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"1697_CR15","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/CED\/LLAD034","volume":"48","author":"ID Brown","year":"2023","unstructured":"Brown ID, Adawi W, Saal R, Perkins-Holtsclaw K, Roberts A. Associations between hidradenitis suppurativa and dermatological conditions in adults: a national cross-sectional study. Clin Exp Dermatol. 2023;48(5):524\u20137. https:\/\/doi.org\/10.1093\/CED\/LLAD034.","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"1697_CR16","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1001\/JAMADERMATOL.2018.5230","volume":"155","author":"R Tannenbaum","year":"2019","unstructured":"Tannenbaum R, Strunk A, Garg A. Association between hidradenitis suppurativa and lymphoma. JAMA Dermatol. 2019;155(5):624\u20135. https:\/\/doi.org\/10.1001\/JAMADERMATOL.2018.5230.","journal-title":"JAMA Dermatol"},{"key":"1697_CR17","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jaad.2018.10.008","volume":"80","author":"S Rastogi","year":"2019","unstructured":"Rastogi S, Patel KR, Singam V, Ali Y, Gao J, Amin A, et\u00a0al. Vulvar cancer association with groin hidradenitis suppurativa: a large, urban, midwestern US patient population study. J Am Acad Dermatol. 2019;80:808\u201310. https:\/\/doi.org\/10.1016\/j.jaad.2018.10.008.","journal-title":"J Am Acad Dermatol"},{"key":"1697_CR18","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.jaad.2014.09.012","volume":"71","author":"J Shlyankevich","year":"2014","unstructured":"Shlyankevich J, Chen AJ, Kim GE, Kimball AB. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis. J Am Acad Dermatol. 2014;71:1144\u201350. https:\/\/doi.org\/10.1016\/j.jaad.2014.09.012.","journal-title":"J Am Acad Dermatol"},{"key":"1697_CR19","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1111\/IJD.16228","volume":"61","author":"O Sokumbi","year":"2022","unstructured":"Sokumbi O, Hodge DO, Ederaine SA, Alavi A, Alikhan A. Comorbid diseases of hidradenitis suppurativa: a 15-year population-based study in Olmsted County, Minnesota, USA. Int J Dermatol. 2022;61:1372\u20139. https:\/\/doi.org\/10.1111\/IJD.16228.","journal-title":"Int J Dermatol"},{"key":"1697_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.07.205","volume":"91","author":"S Thakker","year":"2024","unstructured":"Thakker S, Samynathan A, Bakhshi P, Hochman E, Wikholm C, Pasieka H. 48782 hidradenitis suppurativa-associated cutaneous squamous cell carcinoma: a cross-sectional analysis of the National Inpatient Sample. J Am Acad Dermatol. 2024;91:AB50. https:\/\/doi.org\/10.1016\/j.jaad.2024.07.205.","journal-title":"J Am Acad Dermatol"},{"key":"1697_CR21","doi-asserted-by":"publisher","first-page":"e1107","DOI":"10.1111\/JDV.19136","volume":"37","author":"AMJ Bailey","year":"2023","unstructured":"Bailey AMJ, Li HOY, Tan MG, Kirchhof MG. Association of hidradenitis suppurativa and malignancy: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2023;37:e1107\u20138. https:\/\/doi.org\/10.1111\/JDV.19136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"1697_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/CANCERS13051153","volume":"13","author":"E Racanelli","year":"2021","unstructured":"Racanelli E, Jfri A, Gefri A, O\u2019brien E, Litvinov IV, Zubarev A, et\u00a0al. Cutaneous squamous cell carcinoma in patients with hidradenitis suppurativa. Cancers (Basel). 2021;13(5):1\u201312. https:\/\/doi.org\/10.3390\/CANCERS13051153.","journal-title":"Cancers (Basel)"},{"key":"1697_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28114413","author":"SS Sohrab","year":"2023","unstructured":"Sohrab SS, Raj R, Nagar A, Hawthorne S, Paiva-Santos AC, Kamal MA, et\u00a0al. Chronic inflammation\u2019s transformation to cancer: a nanotherapeutic paradigm. Molecules. 2023. https:\/\/doi.org\/10.3390\/molecules28114413.","journal-title":"Molecules"},{"key":"1697_CR24","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jaad.2019.10.044","volume":"82","author":"P Acharya","year":"2020","unstructured":"Acharya P, Mathur M. Hidradenitis suppurativa and smoking: a systematic review and meta-analysis. J Am Acad Dermatol. 2020;82:1006\u201311. https:\/\/doi.org\/10.1016\/j.jaad.2019.10.044.","journal-title":"J Am Acad Dermatol"},{"key":"1697_CR25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jaad.2018.02.053","volume":"79","author":"A Garg","year":"2018","unstructured":"Garg A, Papagermanos V, Midura M, Strunk A, Merson J. Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: a population-based analysis in the United States. J Am Acad Dermatol. 2018;79:495-500.e1. https:\/\/doi.org\/10.1016\/j.jaad.2018.02.053.","journal-title":"J Am Acad Dermatol"},{"key":"1697_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/jdv.16677","volume":"35","author":"TV Nguyen","year":"2021","unstructured":"Nguyen TV, Damiani G, Orenstein LAV, Hamzavi I, Jemec GB. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol. 2021;35:50\u201361. https:\/\/doi.org\/10.1111\/jdv.16677.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1697_CR27","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.15419\/bmrat.v5i4.428","volume":"5","author":"Y Khani","year":"2018","unstructured":"Khani Y, Khani Y, Pourgholam-Amiji N, Afshar M, Otroshi O, Sharifi-Esfahani M, et\u00a0al. Tobacco smoking and cancer types: a review. Biomed Res Ther. 2018;5:2142\u201359. https:\/\/doi.org\/10.15419\/bmrat.v5i4.428.","journal-title":"Biomed Res Ther"},{"key":"1697_CR28","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/1744666X.2020.1754194","volume":"16","author":"ND Loft","year":"2020","unstructured":"Loft ND, Vaengebjerg S, Skov L. Cancer risk in patients with psoriasis: should we be paying more attention? Expert Rev Clin Immunol. 2020;16:479\u201392. https:\/\/doi.org\/10.1080\/1744666X.2020.1754194.","journal-title":"Expert Rev Clin Immunol"},{"issue":"5","key":"1697_CR29","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMOA1504370","volume":"375","author":"AB Kimball","year":"2016","unstructured":"Kimball AB, Okun MM, Williams DA, Gottlieb AB, Papp KA, Zouboulis CC, et\u00a0al. Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med. 2016;375(5):422\u201334. https:\/\/doi.org\/10.1056\/NEJMOA1504370.","journal-title":"N Engl J Med"},{"issue":"2","key":"1697_CR30","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/IWJ.12671","volume":"14","author":"N Jourabchi","year":"2017","unstructured":"Jourabchi N, Fischer AH, Cimino-Mathews A, Waters KM, Okoye GA. Squamous cell carcinoma complicating a chronic lesion of hidradenitis suppurativa: a case report and review of the literature. Int Wound J. 2017;14(2):435\u20138. https:\/\/doi.org\/10.1111\/IWJ.12671.","journal-title":"Int Wound J"},{"key":"1697_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/DSS.0000000000000944","volume":"43","author":"GM Makris","year":"2017","unstructured":"Makris GM, Poulakaki N, Papanota AM, Kotsifa E, Sergentanis TN, Psaltopoulou T. Vulvar, perianal and perineal cancer after hidradenitis suppurativa: a systematic review and pooled analysis. Dermatol Surg. 2017;43:107\u201315. https:\/\/doi.org\/10.1097\/DSS.0000000000000944.","journal-title":"Dermatol Surg"},{"issue":"2","key":"1697_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000269836","volume":"220","author":"C Lavogiez","year":"2010","unstructured":"Lavogiez C, Delaporte E, Darras-Vercambre S, De Lassalle EM, Castillo C, Mirabel X, et\u00a0al. Clinicopathological study of 13 cases of squamous cell carcinoma complicating hidradenitis suppurativa. Dermatology. 2010;220(2):147\u201353. https:\/\/doi.org\/10.1159\/000269836.","journal-title":"Dermatology"},{"key":"1697_CR33","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jaad.2017.02.005","volume":"77","author":"A Garg","year":"2017","unstructured":"Garg A, Lavian J, Lin G, Strunk A, Alloo A. Incidence of hidradenitis suppurativa in the United States: a sex- and age-adjusted population analysis. J Am Acad Dermatol. 2017;77:118\u201322. https:\/\/doi.org\/10.1016\/j.jaad.2017.02.005.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1697_CR34","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.jaad.2015.11.028","volume":"74","author":"A Kailas","year":"2016","unstructured":"Kailas A, Solomon JA, Mostow EN, Rigel DS, Kittles R, Taylor SC. Gaps in the understanding and treatment of skin cancer in people of color. J Am Acad Dermatol. 2016;74(5):1020\u20131. https:\/\/doi.org\/10.1016\/j.jaad.2015.11.028.","journal-title":"J Am Acad Dermatol"},{"key":"1697_CR35","first-page":"307","volume":"99","author":"BP Kaufman","year":"2017","unstructured":"Kaufman BP, Alexis AF. Skin cancer mortality in patients with skin of color. Cutis. 2017;99:307.","journal-title":"Cutis"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01697-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01697-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01697-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:38:05Z","timestamp":1775101085000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01697-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1697"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01697-y","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Daniel Isufi and Mikkel Bak Jensen report no conflict of interest. Nikolai Loft reports research grant funding from the Leo Foundation and reports that he has been a paid speaker for Eli Lilly, Janssen Cilag, and Sandoz. Rune Kj\u00e6rsgaard Andersen reports research grant funding from the Leo Foundation and reports that his attendance at the 2022 Nordic Congress of DermatoVenerology was funded by Eli Lilly.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}